Analystreport

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) was upgraded by analysts at Roth Capital from a "neutral" rating to a "buy" rating. They now have a $4.00 price target on the stock.

Tonix Pharmaceuticals Holding Corp.  (TNXP) 
Last tonix pharmaceuticals holding corp. earnings: 3/24 05:15 pm Check Earnings Report
US:NASDAQ Investor Relations: tonixpharma.com